Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits
Patients with recurrent PDAC characterized by "TTR >12 months" and "SOR with ≤3 tumors" may achieve long-term survival with LT, leading to the proposal of defining them as having "oligo-recurrence" in PDAC.
Authors
- Kei Yamane (ORCID: https://orcid.org/0000-0002-9543-0841)
- Koshiro Morino (ORCID: https://orcid.org/0000-0002-9295-0833)
- Takashi Ito (ORCID: https://orcid.org/0000-0002-5892-8317)
- Takamichi Ishii (ORCID: https://orcid.org/0000-0002-7461-9653)
- Satoshi Ogiso (ORCID: https://orcid.org/0000-0002-9577-330X)
- Kazuyuki Nagai (ORCID: https://orcid.org/0000-0003-2180-2056)
- Michio Yoshimura (ORCID: https://orcid.org/0000-0001-6665-2245)
- Takayuki Anazawa (ORCID: https://orcid.org/0000-0002-7625-5750)
- Takahiro Iwai (ORCID: https://orcid.org/0000-0003-0078-9235)
- Yu Hidaka (ORCID: https://orcid.org/0000-0003-3637-4429)
- Yoichiro Uchida (ORCID: https://orcid.org/0000-0003-2266-7722)
- Akihisa Fukuda (ORCID: https://orcid.org/0000-0002-1940-596X)
- Asahi Sato (ORCID: https://orcid.org/0000-0002-0985-9394)
- Hiroyoshi Isoda
- Yumiko Ibi
- Etsuro Hatano (ORCID: https://orcid.org/0000-0003-3407-1918)
- Junichi Matsubara (ORCID: https://orcid.org/0000-0003-0116-5133)
Institutions
- Kyoto University (JP)
- Tenri Hospital (JP)
Publication Details
- Journal
- Pancreatology
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1016/j.pan.2025.04.012
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14